Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita Japan.
Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Am Surg. 2023 Dec;89(12):5660-5668. doi: 10.1177/00031348221114042. Epub 2023 Apr 26.
Application of laparoscopic gastrectomy (LG) to advanced gastric cancer is still controversial due to lack of sufficient surgical and oncological outcomes. The purpose of this study was to elucidate the feasibility of LG for advanced gastric cancer by multicenter prospective cohort study.
A total of 98 patients with clinical stage II or III gastric cancer from 8 institutes were analyzed in this study. The primary endpoint was incidence of severe postoperative complications of Clavien-Dindo classification grade Ⅲa or higher.
Sixty-six patients underwent laparoscopic distal gastrectomy (LDG), 10 patients laparoscopic proximal gastrectomy (LPG), 21 patients laparoscopic total gastrectomy (LTG), and 1 patient received gastro-jejunostomy. Seven patients had positive lavage cytology (CY1) and R0 rate was 90.8%. Three patients (3.1%) required conversion to open surgery. The incidence of overall postoperative complications and severe postoperative complications were 17.3% and 9.2%, respectively, those were comparable to the data of open surgery for advanced gastric cancer previously published. By surgical procedure, the incidence of severe postoperative complications of LDG, LPG, and LTG were 4.6, 0, and 28.6% and the rate of severe anastomotic leakage of LDG, LPG, and LTG were 0, 0, and 9.5%, respectively. Total gastrectomy was an only independent risk factor of severe postoperative complications in LG for advanced gastric cancer (odds ratio 8.75; 95% confidence interval 1.70-56.69, P = .0092).
The incidence of severe postoperative complications after LG performed by qualified surgeons was acceptable even in cases of advanced gastric cancer; however, careful attention is required to adopt LTG. (UMIN000025733).
由于缺乏足够的手术和肿瘤学结果,腹腔镜胃切除术(LG)在进展期胃癌中的应用仍存在争议。本研究旨在通过多中心前瞻性队列研究阐明 LG 治疗进展期胃癌的可行性。
本研究分析了来自 8 家医院的 98 例临床分期为 II 期或 III 期胃癌患者。主要终点是 Clavien-Dindo 分级Ⅲa 或更高等级严重术后并发症的发生率。
66 例患者行腹腔镜远端胃切除术(LDG),10 例患者行腹腔镜近端胃切除术(LPG),21 例患者行腹腔镜全胃切除术(LTG),1 例患者行胃空肠吻合术。7 例患者有阳性冲洗细胞学(CY1),R0 率为 90.8%。3 例(3.1%)需要转为开放手术。总的术后并发症和严重术后并发症的发生率分别为 17.3%和 9.2%,与先前发表的进展期胃癌开放手术数据相当。按手术方式,LDG、LPG 和 LTG 的严重术后并发症发生率分别为 4.6%、0%和 28.6%,LDG、LPG 和 LTG 的严重吻合口漏发生率分别为 0%、0%和 9.5%。全胃切除术是 LG 治疗进展期胃癌严重术后并发症的唯一独立危险因素(比值比 8.75;95%置信区间 1.70-56.69,P =.0092)。
即使在进展期胃癌患者中,由合格外科医生施行的 LG 术后严重术后并发症的发生率也是可以接受的;然而,需要小心注意采用 LTG。(UMIN000025733)。